Slusarczyk J, Michalak T, Krawczynski K, NOWOSLAWSKI A
Am J Pathol. 1980; 98(1):29-43.
PMID: 7350816
PMC: 1903406.
Nydegger U, Lambert P, Gerber H, MIESCHER P
J Clin Invest. 1974; 54(2):297-309.
PMID: 4847246
PMC: 301557.
DOI: 10.1172/JCI107765.
Barker L, Almeida J, Hoofnagle J, Gerety R, Jackson D, McGrath P
J Virol. 1974; 14(6):1552-8.
PMID: 4431086
PMC: 355685.
DOI: 10.1128/JVI.14.6.1552-1558.1974.
Gerber M, Hadziyannis S, Vissoulis C, Schaffner F, Paronetto F, Popper H
Am J Pathol. 1974; 75(3):489-502.
PMID: 4134380
PMC: 1910854.
Trepo C, Robert D, MOTIN J, Trepo D, SEPETJIAN M, Prince A
Gut. 1976; 17(1):10-13.
PMID: 1269974
PMC: 1411056.
DOI: 10.1136/gut.17.1.10.
HBc and HBs antigen in hepatocytes.
Shikata T, Yoshizaki C, Okazaki K, Uzawa T, Matsushita H
Gastroenterol Jpn. 1975; 10(3):199-207.
PMID: 1234097
DOI: 10.1007/BF02776653.
The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HBsAg), hepatitis-B-core-antigen (HBcAg) and IgG for the classification of inflammatory liver diseases. (Studies on HBsAg-positive and -negative patients).
Arnold W, Meyer zum Buschenfelde K, Hess G, Knolle J
Klin Wochenschr. 1975; 53(22):1069-74.
PMID: 1226039
DOI: 10.1007/BF01614383.
Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus.
Gerin J, Ford E, Purcell R
Am J Pathol. 1975; 81(3):651-68.
PMID: 1211425
PMC: 2032329.
Clinical pathologic correlation in viral hepatitis. The effect of the virus on the liver.
Popper H
Am J Pathol. 1975; 81(3):609-28.
PMID: 1108667
PMC: 2032326.
Antiviral effects of virazole in chronic hepatitis B surface antigen-seropositive chimpanzees.
Denes A, Ebert J, Berquist K, Murphy B, MAYNARD J
Antimicrob Agents Chemother. 1976; 10(3):571-2.
PMID: 984798
PMC: 429791.
DOI: 10.1128/AAC.10.3.571.
Application of a screening test for antibody the hepatitis B core antigen.
Cohen B, Cossart Y
J Clin Pathol. 1977; 30(8):709-13.
PMID: 599183
PMC: 476529.
DOI: 10.1136/jcp.30.8.709.
HBsAg immune complexes in the course of infection with hepatitis B virus.
Madalinski K, BRAGIEL I
Clin Exp Immunol. 1979; 36(3):371-8.
PMID: 487641
PMC: 1537759.
The etiology of chronic active hepatitis in Korea.
Prince A, GERSHON R
Yale J Biol Med. 1979; 52(2):159-67.
PMID: 377825
PMC: 2595445.
A direct immunofluorescence method for the detection of hepatitis B core antigen in formalin-fixed and gelatin-embedded liver specimens.
Yoshizawa H, Itoh Y, Akahane Y, Tsuda F, Miyakawa Y, Mayumi M
J Clin Pathol. 1977; 30(8):776-8.
PMID: 340475
PMC: 476546.
DOI: 10.1136/jcp.30.8.776.
Immunohistochemical patterns of hepatitis B surface antigen (HBsAg) in patients with hepatitis, renal homografts recipients and normal carriers.
Camilleri J, Amat C, Chousterman M, PETITE J, Duboust A, Boddaert A
Virchows Arch A Pathol Anat Histol. 1977; 376(4):329-41.
PMID: 145724
DOI: 10.1007/BF00432302.
Demonstration of hepatitis B surface antigen by orcein staining in paraffin sections of cirrhotic liver.
BARTOK I, Remenar E, Toth J
Virchows Arch A Pathol Anat Histol. 1976; 369(3):239-48.
PMID: 56804
DOI: 10.1007/BF00427712.
Localization of hepatitis B surface antigen in conventional paraffin sections of the liver. Comparison of immunofluorescence, immunoperoxidase, and orcein staining methods with regard to their specificity and reliability as antigen marker.
Nayak N, Sachdeva R
Am J Pathol. 1975; 81(3):479-92.
PMID: 55076
PMC: 2032332.
Serology and epidemiology.
Walsh J
West J Med. 1975; 123(3):206-10.
PMID: 51538
PMC: 1130378.
